Results 61 to 70 of about 45,205 (210)

Identification of VLDL as a biomarker for prewarning of androgenic alopecia.

Skin Res Technol
Shen Y, Xu W, Sun J, Zhu Y, Dai Y, Song X.   +5 more
europepmc   +3 more sources

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Journal of Internal Medicine, Volume 300, Issue 5, Page 590-609, November 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund, Johanna Melin, Anju E. Joham, Terhi T. Piltonen, D. Aled Rees, Helena J. Teede   +5 more
wiley   +1 more source

Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans

Biomedical Chromatography, Volume 40, Issue 10, October 2026.
ABSTRACT RU 58841 is a nonsteroidal antiandrogen, developed for the treatment of androgen‐dependent conditions. This study aimed to characterize the human metabolism of RU 58841 for the first time and to assess its systemic exposure following topical administration.
Aylin Okutan, Oliver Krug, Gregor Fußhöller, Thomas Piper, Mario Thevis   +4 more
wiley   +1 more source

Modern techniques in the management of androgenic alopecia

, 2021
Androgenic alopecia is a disease that affects many people's lifestyle and mental health. Many treatments have been discovered and are used widely. Finasteride, Minoxidil, ketoconazole shampoo are some examples of the treatments. Modern techniques such as
Park, Jun Hwan
core  

Will it ever grow back? The psychosocial impacts of alopecia

, 2021
Alopecia is a common clinical complaint in the offices of family physicians and dermatologists. Here, we discuss common subtypes of alopecia, including androgenic alopecia and alopecia areata.
Riahi, Aryan
core   +1 more source

Development of emulgel technology with saw palmetto extracts and of japanese sophora tincture for androgenetic alopecia treatment

Фармацевтичний журнал, 2018
Androgenic alopecia is a hair disease caused by an excessive influence of androgens on hair follicles, whose treatment requires long-term use of systemic and / or local action drugs.
I. O. Yarema, M. I. Feodorovska, N. P. Polovkо   +2 more
doaj   +1 more source

Association of Knowledge, Dietary Behaviors, and Attitudes Toward Hair Problems Among the Population in the Chattogram Division, Bangladesh: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims Hair health is influenced by sociodemographic characteristics, dietary habits, and knowledge. Despite increased global attention to hair‐related concerns, research on hair care knowledge and behaviors remains scarce in low‐resource nations like Bangladesh. The purpose of this study was to determine the demographic variables
Rakibur Rahman, Yasin Arafat, Md. Meherajul Kabir, Samiha Siddique, Tasnim Rahman, Nur e Shyma Fatema, Sakib Bin Nour, Md. Rashedur Rahman, Shuchana das, Fatema Tuz Zohura, Cinmoy Barua, Md. Masudur Rahman, Md. Sohel Rana, Mohammad Nazmul Islam   +13 more
wiley   +1 more source

Additional file 5: of Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis

, 2018
Table S4. Meta-analysis results of association between androgenic alopecia and incidence of cancer.
Liuying Song (4453945), Yan Zou (309215), Shengming Dai (701276), Weijun Liang (4037741), Zheng Peng (727768)   +4 more
core   +1 more source

Sustained induction of PMOS‐like phenotype in mice exposed to letrozole in drinking water

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS; formerly polycystic ovary syndrome) is the most common endocrinopathy affecting women of reproductive age, characterized by ovarian dysfunction and hyperandrogenism, with metabolic disturbances including insulin resistance and obesity also present for 50% of PMOS patients.
Kennedy A. Stevenson, Romy Kerbus, Greg M. Anderson, Caroline Decourt   +3 more
wiley   +1 more source

Is Platelet Rich Plasma Injection an Effective Treatment for Hair Loss in Androgenic Alopecia and Alopecia Areata? [PDF]

, 2017
Objective: The objective of this selective EBM review is to determine whether or not Platelet Rich Plasma is efficacious in regrowth of hair in both androgenic alopecia and alopecia areata. Study Design: Review of two blinded randomized controlled trials
Stanczak, Maciej
core   +1 more source